help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 6, 2007
Molecular Endocrinology, doi:10.1210/me.2007-0053
A more recent version of this article appeared on May 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
21/5/1205    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhu, X.
Right arrow Articles by Ezzat, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, X.
Right arrow Articles by Ezzat, S.

Submitted on January 26, 2007
Accepted on February 26, 2007

Ikaros is Regulated Through Multiple Histone Modifications and DNA Methylation in the Pituitary

Xuegong Zhu, Sylvia L. Asa, and Shereen Ezzat*

Department of Medicine, Mount Sinai Hospital and University of Toronto; Department of Pathology, University Health Network and University of Toronto; The Freeman Centre for Endocrine Oncology and The Ontario Cancer Institute, 610 University Avenue, Toronto, Ontario, Canada M5G-2M9

* To whom correspondence should be addressed. E-mail: shereen.ezzat{at}utoronto.ca.

The transcription factor Ikaros (Ik) is at the centre of a functionally diverse chromatin-remodeling network that is critical for the development and regulation of both the immune and endocrine systems. Dominant negative forms of Ik result in neoplastic growth in mouse genetic studies and have been identified in human tumors. Ik modulates chromatin accessibility through associations with members of the NURD complex including histone deacetylase complexes (HDAC). We show here that Ik expression in mouse pituitary corticotroph cells is itself regulated through histone modifications as well as DNA methylation. Examination of primary human pituitary specimens also identified a correlation of loss of Ik expression with the presence of DNA methylation in untranslated exon 1 CpG island. These findings have important implications for the understanding of Ikaros' role in epigenetic functions and suggest a potential role for demethylating agents in the treatment of related disorders.


Key words: Ikaros • histone deacetylation • histone methylation • histone acetylation • epigenetic control




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Loeper, S. L. Asa, and S. Ezzat
Ikaros Modulates Cholesterol Uptake: A Link between Tumor Suppression and Differentiation
Cancer Res., May 15, 2008; 68(10): 3715 - 3723.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society